Publications by authors named "G O Babalola"

This study evaluated the impact of pesticide application through agricultural activities in Chanchaga River, Nigeria, using macroinvertebrate data sets obtained for six months (September 2021-February 2022). Four (4) stations, characterized by various agricultural activities, were sampled along the river. Analysis of the water samples for organochlorine pesticide residues (OCP) using Gas Chromatography-Mass Spectrometry (GC/MS) at the peak of the two seasons revealed a high concentration of eleven isomers of organochlorine, which ranged from 0.

View Article and Find Full Text PDF

Robots present an opportunity to enhance healthcare delivery. Rather than targeting complete automation and nurse replacement, collaborative robots, or "cobots", might be designed to allow nurses to focus on high-value caregiving. While many institutions are now investing in these platforms, there is little publicly available data on how cobots are being developed, implemented, and evaluated to determine if and how they support nursing practice in the real world.

View Article and Find Full Text PDF

Background: The world began to realise the impact of the coronavirus disease 2019 (COVID-19) in January 2020, and since then the number of people infected has exceeded 1 million globally. In less than 1 month following the first reported case in Nigeria, over 180 people had tested positive to the disease. Studies have shown that such rapidly spreading infectious diseases have the potential to create widespread fear, apprehension, panic and anxiety amongst the general public.

View Article and Find Full Text PDF

Background: Patients who have suffered an acute ischemic stroke (AIS) and are smokers may have a better outcome following thrombolytic therapy when compared with non-smokers. While this finding is controversial, data on baseline clinical risk factors to predict treatment efficacy of thrombolytic therapy using ambulatory status in patients who suffered AIS and are smokers is not common.

Methods: Between 2010 and 2016, retrospective data on patients who have suffered an AIS and received recombinant tissue plasminogen activator (rtPA) were obtained from Greenville health system registry.

View Article and Find Full Text PDF